Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab-Reference-Cited by-同舟云学术

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab

Published:2015-03-23 Issue:1 Volume:17 Page:
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

de Jong Tamarah D,Vosslamber Saskia,Blits Marjolein,Wolbink Gertjan,Nurmohamed Mike T,van der Laken Conny J,Jansen Gerrit,Voskuyl Alexandre E,Verweij Cornelis L

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1186/s13075-015-0564-y.pdf

Reference23 articles.

1. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69:964–75.

2. Thurlings RM, Boumans M, Tekstra J, van Roon JA, Vos K, van Westing DM, et al. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. Arthritis Rheum. 2010;62:3607–14.

3. Raterman HG, Vosslamber S, De RS, Nurmohamed MT, Lems WF, Boers M, et al. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients. Arthritis Res Ther. 2012;14:R95.

4. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rustenburg F, Baggen JM, et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis. 2007;66:1008–14.

5. Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14:36–49.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors;Expert Review of Clinical Immunology;2024-08-18

2. Hyperinsulinemia counteracts inflammation by suppressing IFNγ and inducing senescence in CD4⁺T cells of patients with rheumatoid arthritis;2024-03-10

3. Pathophysiology and stratification of treatment-resistant rheumatoid arthritis;Immunological Medicine;2023-07-18

4. Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response;The Journal of Rheumatology;2023-07-01

5. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice;Annals of the Rheumatic Diseases;2023-03-01